National Health (Listed drugs on F1 or F2) Amendment Determination 2014 (No. 12) (No. PB 105 of 2014) (Cth)

PB 105 of 2014

National Health (Listed drugs on F1 or F2) Amendment Determination 2014 (No. 12)

National Health Act 1953

I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated              22           December 2014

ADRIANA PLATONA

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health

Part 1         Preliminary

1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2014 (No. 12).

(2)   This Determination may also be cited as PB 105 of 2014.

1. Commencement

This Determination commences on 1 January 2015.

1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Eltrombopag

Insert

Empagliflozin

[2]     Schedule 1, after item dealing with Sodium bicarbonate

Omit

Sodium chloride compound